Marisha Burden, MD, MBA; Gopi Astik, MD, MS; Andrew Auerbach, MD; et al.
open access
JAMA Intern Med. 2024;184(9):1014-1023. doi:10.1001/jamainternmed.2024.1890
This qualitative study using a mixed-methods approach examines the identification of and proposed measures to address administrative harms.
-
Editor's Note
Administrative Harms—Common and Sometimes Preventable
Ishani Ganguli, MD, MPH; Mitchell H. Katz, MD
JAMA Intern Med
Linda N. Geng, MD, PhD; Hector Bonilla, MD; Haley Hedlin, PhD; et al.
open access
JAMA Intern Med. 2024;184(9):1024-1034. doi:10.1001/jamainternmed.2024.2007
This randomized clinical trial evaluates the efficacy of oral nirmatrelvir-ritonavir for treatment of moderate to severe postacute sequelae of SARS-CoV-2 infection of 3 months or longer duration.
Ryuichiro Yagi, MD, MPH; Yuichiro Mori, MD, MPH; Shinichi Goto, MD, PhD; et al.
open access
JAMA Intern Med. 2024;184(9):1035-1044. doi:10.1001/jamainternmed.2024.2270
This cohort study examines the use of routine electrocardiogram (ECG) screening in identifying individuals at risk for cardiovascular disease.
Fiona Streckmann, PhD; Thomas Elter, PD; Helmar C. Lehmann, PD; et al.
JAMA Intern Med. 2024;184(9):1046-1053. doi:10.1001/jamainternmed.2024.2354
This randomized clinical trial assesses whether sensorimotor training and whole-body vibration training reduce symptoms and decrease the onset of chemotherapy-induced peripheral neuropathy.
Patricia J. Rodriguez, PhD; Brianna M. Goodwin Cartwright, MS; Samuel Gratzl, PhD; et al.
open access
JAMA Intern Med. 2024;184(9):1056-1064. doi:10.1001/jamainternmed.2024.2525
This cohort study compares treatment-associated weight loss and rates of gastrointestinal adverse events among adults with overweight or obesity receiving tirzepatide or semaglutide labeled for type 2 diabetes in a clinical setting.
Justin Markowski, MA, MPH, PhD; Jacob Wallace, PhD; Mark Schlesinger, PhD; et al.
JAMA Intern Med. 2024;184(9):1065-1073. doi:10.1001/jamainternmed.2024.2754
This cohort study examines whether Medicaid alternative payment models are associated with the health care quality, health outcome measures, payer mix, and risk profile of federally qualified health centers.
Katie Fitzgerald Jones, PhD, ACHPN, CARN-AP; Dustin M. Long, PhD; Matthew J. Bair, MD, MS; et al.
JAMA Intern Med. 2024;184(9):1074-1082. doi:10.1001/jamainternmed.2024.3071
This randomized clinical trial assessed the efficacy of a behavioral pain self-management program compared with enhanced usual care in patients with HIV and chronic pain.
Kelly C. Young-Wolff, PhD, MPH; Sara R. Adams, MPH; Stacey E. Alexeeff, PhD; et al.
open access
has audio
JAMA Intern Med. 2024;184(9):1083-1093. doi:10.1001/jamainternmed.2024.3270
This cohort study examines the association between prenatal cannabis use and maternal health outcomes during pregnancy.
-
Podcast:
Prenatal Cannabis Use and Maternal Pregnancy Outcomes
Diann E. Gaalema, PhD; Sherrie Khadanga, MD; Patrick D. Savage, MS; et al.
JAMA Intern Med. 2024;184(9):1095-1104. doi:10.1001/jamainternmed.2024.3338
This randomized clinical trial assesses the efficacy of early case management, financial incentives, and their combination for increasing cardiac rehabilitation adherence among patients with lower socioeconomic status.
Jennifer McNeely, MD, MS; Scarlett S. Wang, MPH, MSW; Yasna Rostam Abadi, MD, MPH; et al.
JAMA Intern Med. 2024;184(9):1106-1115. doi:10.1001/jamainternmed.2024.3422
This randomized clinical trial examines the effectiveness of interprofessional hospital addiction consultation services in increasing medication for opioid use disorder treatment initiation and engagement.